NewsBenzinga会議通話: AbbVie、2026年度売上高見通しを676億ドルから678億ドルに引き上げ ― 市場予想675.85億ドルを上回る 会議通話: AbbVie、2026年度売上高見通しを676億ドルから678億ドルに引き上げ ― 市場予想675.85億ドルを上回る Benzinga 2026.10.30 13:44 (GMT+0) Open on Benzinga Other news Freedom Broker Maintains Buy on XPeng, Lowers Price Target to $20 Plug Power Shares Slide Toward 52-Week Low Despite New 280-MW Texas Deal Nvidia Vs. Anthropic: Can the AI IPO Challenge Nvidia’s Dominance Across ETFs? Freedom Broker Maintains Buy on Allot, Lowers Price Target to $12.7 Freedom Broker Upgrades M-Tron Industries to Buy, Lowers Price Target to $84 As decision model use skyrockets, is customization is the next frontier?